v3.26.1
Business Combinations and Divestments (Details)
$ in Millions, $ in Millions
1 Months Ended 4 Months Ended 12 Months Ended
Feb. 03, 2025
EUR (€)
item
Jan. 02, 2025
EUR (€)
Jul. 01, 2024
EUR (€)
Apr. 01, 2024
USD ($)
Jul. 07, 2023
EUR (€)
Feb. 28, 2025
Center
Feb. 03, 2025
EUR (€)
Jan. 31, 2025
Center
Jun. 30, 2023
item
Jul. 31, 2024
EUR (€)
Center
Dec. 31, 2025
EUR (€)
Center
Dec. 31, 2025
USD ($)
Center
Dec. 31, 2024
EUR (€)
Dec. 31, 2023
EUR (€)
[1]
Dec. 31, 2018
Dec. 31, 2016
EUR (€)
May 01, 2025
Feb. 03, 2025
USD ($)
Jan. 02, 2025
USD ($)
Jul. 31, 2024
USD ($)
Jul. 01, 2024
USD ($)
Oct. 09, 2023
EUR (€)
Jul. 07, 2023
CAD ($)
Disclosure of detailed information about business combination [line items]                                              
Group companies, associates and business units, total net cash amount                     € 108,000,000   € 286,000,000 € 29,000,000                  
Albajuna Therapeutics, S.L.                                              
Disclosure of detailed information about business combination [line items]                                              
Percentage of shareholding                             49.00% 30.00%              
Purchase of interests in investments accounted for using equity method                               € 4,000,000              
Grifols Canada Plasma, Inc.                                              
Disclosure of detailed information about business combination [line items]                                              
Percentage of interest         100.00%                                    
Plasma centers acquired from Immunotek                                              
Disclosure of detailed information about business combination [line items]                                              
Number of plasma centers acquired | Center           6   8   14                          
Total number of plasma centers managed by entity                                 28            
Number of guarantees over lease contracts released | item 3                                            
Total number of guarantees over lease contracts | item 2               5                            
Remaining guarantees with an amount total | $                                   $ 20          
Consideration                   € 514,000,000                   $ 547      
Group 1 centers and Group 2 centers                                              
Disclosure of detailed information about business combination [line items]                                              
Number of plasma centers acquired                   14                          
Consideration                   € 246,000,000                   266      
Step-up of net assets acquired                   0 € (3,000,000) $ (3)                      
Goodwill                   246,000,000                   266      
Adjustments from acquisition                   (10,000,000)                   (10)      
Goodwill, net of adjustments                   € 236,000,000                   $ 256      
Group 1 centers                                              
Disclosure of detailed information about business combination [line items]                                              
Number of plasma centers acquired       7                                      
Consideration     € 121,000,000 $ 135                                      
Group 2 centers                                              
Disclosure of detailed information about business combination [line items]                                              
Number of plasma centers acquired     7                                        
Consideration     € 125,000,000                                   $ 131    
Group 3 centers and Group 4 centers                                              
Disclosure of detailed information about business combination [line items]                                              
Number of plasma centers acquired                     14 14                      
Consideration € 268,000,000           € 268,000,000         $ 140 € 134,000,000         281          
Advance payment (134,000,000)           (134,000,000)                     (140)          
Net consideration 134,000,000           134,000,000                     141          
Step-up of net assets acquired             0                                
Goodwill 268,000,000           268,000,000                     281          
Adjustments from acquisition (27,000,000)           (27,000,000)                     (28)          
Goodwill, net of adjustments € 241,000,000           241,000,000                     253          
Group 3 centers                                              
Disclosure of detailed information about business combination [line items]                                              
Number of plasma centers acquired   8                                          
Consideration   € 75,000,000                                 $ 79        
Group 4 centers                                              
Disclosure of detailed information about business combination [line items]                                              
Number of plasma centers acquired 6                   6 6                      
Liabilities incurred € 60,000,000           60,000,000                     70          
Management fee and finance costs on deferred consideration 7,000,000           7,000,000                     8          
Consideration € 59,000,000           € 59,000,000                     $ 62          
Saskatoon plasma center Inc                                              
Disclosure of detailed information about business combination [line items]                                              
Consideration         € 8,000,000                                   $ 12
Goodwill         € 8,000,000                                   $ 11
Albajuna Therapeutics, S.L. Inc.                                              
Disclosure of detailed information about business combination [line items]                                              
Consideration                                           € 1  
Assets acquired (liabilities assumed)                                           2,000,000  
Goodwill                                           2,000,000  
Fair value of net assets acquired                                           € 2,000,000  
[1] (See Note 2.d)